Anthony M, Sorkin EM
1993. Ondansetron an update of its therapeutic use in chemotherapy-induced and
post operative nausea and vomiting. Drugs; 45:931-52.
Balint, A., Silvia, I.M.R.E.,
Bondoroi-Papp, Z. and Muntean, D.L., 2018. Development of a new rp-hplc method
for ondansetron determination in injectable formulations. The Medical-Surgical
Journal, 122(1), pp.207-212.
Deshmukh, T.B., Deo,
S.S., Inam, F., Lambat, T.L., Gurubaxani, S.B. and Choudhari, A.V., 2015.
Development and validation of Ondansetron hydrochloride in pharmaceutical
dosage form by RP-HPLC method. Indian Journal of Advances in Science
Engineering and Technology, 1, pp.15-20.
Gupta, P.K., Ramisetti, N.R.,
Cecchi, T., Swain, S., Patro, C.S. and Panda, J., 2018. An overview of
experimental designs in HPLC method development and validation. Journal of Pharmaceutical
and Biomedical Analysis, 147, pp.590-611.
Gupta, V., Jain,
A.D.K.J., Gill, N.S. and Guptan, K., 2012. Development and validation of HPLC
method-a review. International Research Journal of Pharmaceutical and Applied
Sciences, 2(4), pp.17-25.
Huddart, R., Altman,
R.B. and Klein, T.E., 2019. PharmGKB summary: Ondansetron and tropisetron
pathways, pharmacokinetics and pharmacodynamics. Pharmacogenetics and Genomics, 29(4), p.91.
Khatal, L., More, H., Jadhav, A.,
Kuchekar, B., Dhaneshwar, S. And Polawar, A., 2014. Validated Hplc and Hptlc
Method for Simultaneous Quantitation of Ondansetron Hydrochloride and
Paracetamol in Bulk Drug and Formulation.
Meyyanathan, S.N., Venkatesh,
D.N., Krishnaveni, N., Babu, B., Jeyaprakash, M.R., Raja, R.B., Hemnath, E. and
Suresh, B., 2012. A RP-HPLC method for simultaneous estimation of ondansetron
and ranitidine in pharmaceutical formulation. International Journal of Health and
Allied Sciences, 1(2), p.129.
Mujtaba, A., Kohli, K., Ali, J.
and Baboota, S., 2013. Development of HPTLC method for the estimation of
ondansetron hydrochloride in bulk drug and sublingual tablets. Drug Testing and
Analysis, 5(2), pp.122-125.
Patel, R.B., Patel,
M.R., Bhatt, K.K. and Patel, B.G., 2010. HPTLC method development and
validation: quantification of paliperidone in formulations and in vitro release
study. Analytical Methods, 2(5), pp.525-531.
Patra S, Choudhury AA, Kar RK,
Barik BB. Spectrophotometric method for ondansetron hydrochloride. Indian J
Pharm Sci 2007; 69(6): 840-41. Edn, Merck and Company, Inc., pg. 1224.
Pharmacopeia, Indian. Vol. – 3
Indian Commission. Ghaziabad, Govt. of India: Ministry of Health and Family
Welfare, 2014: 2380-2381.
Prasad CVN, Parihar C, Sunil K and
Parimoop.P, 1989. Simultaneous determination of tinidazole- clotrimazole and
tinidazole- norfloxacin in combined tablet preparations with other drugs.
Journal of the association of official Analytical Chemists;72(3): 432-435.
Rakam, G.K., Mallik, A. and
Sucharitha, C., 2022. Method Development and Validation of Reverse Phase High
Performance Liquid Chromatography Method for Estimation of Ondansetron and
Pantoprazole in their Tablet Dosage Form. Indian Journal of Pharmaceutical
Sciences, 84(2), pp.483-192
Raval, P.B., Puranik, M., Wadher,
S.J. and Yeole, P.G., 2008. A validated HPTLC method for determination of
ondansetron in combination with omeprazole or rabeprazole in solid dosage form.
Indian Journal of Pharmaceutical Sciences, 70(3), p.386.
Ravi Kumar P, Murali Krishna M,
Bhanu prakash P, Anil kumar B and Madhusudhan P 2006. Derivative
Spectrophotometric Estimation of Ondansetron and Paracetamol. E-J Chem; 3(12):
134-36.
Ravisankar, P, Gowthami,
S and Rao, GD, 2014. A review on analytical method development. Indian
Journal of Research in Pharmacy and Biotechnology. ;2(3):1183.
Raza A, Ijaz AS, Atta-ur-Rehman,
Rasheed 2007. Spectrophotometric determination of ondansetron hydrochloride in
pharmaceutical bulk and dosage forms. J Chin Chem Soc; 54: 223-27.
Roila, F. and Del
Favero, A., 1995. Ondansetron clinical pharmacokinetics. Clinical
pharmacokinetics, 29(2), pp.95-109.
Saraya, R.E., Salam, R.A.A. and
Hadad, G.M., 2018. Stability-indicating high-performance thin-layer
chromatographic determination of ondansetron in pure form and pharmaceutical
formulations. JPC-Journal of Planar Chromatography-Modern TLC, 31(2),
pp.122-128.
Stevens, A.J., Woodman, R.J. and
Owen, H., 2015. The effect of ondansetron on the efficacy of postoperative
tramadol: a systematic review and meta‐analysis of a drug interaction.
Anaesthesia, 70(2), pp.209-218.
Suknuntha, K., Wattanapoka, K.,
Poonpattanachai, P., Titipornwanich, N. and Sripakdee, W., 2022. Compatibility
and Physical Properties of Dexamethasone-Ondansetron Intravenous Admixture. Hospital
Pharmacy, 57(5), pp.666-672.
Tanveer, S., Ahmad,
M., Minhas, M.U., Ahmad, A. and Khan, K.U., 2021. Chitosan-PVA-co-poly
(2-acrylamido-2-methylpropane sulfonic acid) cross-linked hybrid IPN-nanogels
for transdermal delivery of ondansetron; synthesis, characterization and
toxicological evaluation. Polymer-Plastics Technology and Materials, 60(17),
pp.1913-1934.
The United State Pharmacopoeia,
24 th ed. Philadelphia: National Publishing; 2000. p. 1218.
Tramèr, M.R., Moore, R.A.,
Reynolds, D.J.M. and McQuay, H.J., 1997. A quantitative systematic review of
ondansetron in treatment of established postoperative nausea and vomiting. BMJ,
314(7087), p.1088.